679 results on '"Saito, K."'
Search Results
2. De Novo Deep Transcriptome Analysis of Medicinal Plants for Gene Discovery in Biosynthesis of Plant Natural Products
- Author
-
Han, R., primary, Rai, A., additional, Nakamura, M., additional, Suzuki, H., additional, Takahashi, H., additional, Yamazaki, M., additional, and Saito, K., additional
- Published
- 2016
- Full Text
- View/download PDF
3. Locomotion rhythm generation using pulse-type hardware neural networks for quadruped robots
- Author
-
Saito, K., primary, Ikeda, Y., additional, Takato, M., additional, and Uchikoba, F., additional
- Published
- 2015
- Full Text
- View/download PDF
4. Contributors
- Author
-
Akcakaya, M., primary, Alers, S., additional, Ambroise, M., additional, Araki, H., additional, Brandão, L., additional, Broeker, B., additional, Caliskanelli, I., additional, Chevrot, C., additional, Claes, D., additional, Dahiya, R., additional, de Boer, M.J., additional, Droogendijk, H., additional, Ellery, A., additional, Festin, N., additional, Frankel, D.J., additional, Guerreiro, J.R.L., additional, Ikeda, Y., additional, Jörntell, H., additional, Kim, S., additional, Krijnen, G.J.M., additional, Levi, T., additional, Mazzoni, A., additional, Moreira, F.T.C., additional, Muravchik, C., additional, Nehorai, A., additional, Nicolas, F., additional, Oddo, C., additional, Omatu, S., additional, Pirim, P., additional, Plesse, C., additional, Ranjbar-Sahraei, B., additional, Saito, K., additional, Saïghi, S., additional, Sales, M.G.F., additional, Sanders, R.G.P., additional, Santulli, C., additional, Takato, M., additional, Tavakoli, M., additional, Tuyls, K., additional, Uchikoba, F., additional, Vidal, F., additional, Viegas, C., additional, Weiss, G., additional, Yarkoni, O., additional, and Yoshida, R., additional
- Published
- 2015
- Full Text
- View/download PDF
5. Constraints on the diffuse photon flux with energies above 10(18) eV using the surface detector of the Telescope Array experiment
- Author
-
Abbasi, R.U., Abe, M., T., Abu-Zayyad, Allen, M., Azuma, R., Barcikowski, E., Belz, J.W., Bergman, D.R., Blake, S.A., Cady, R., Cheon, B.G., Chiba, J., Chikawa, M., di Matteo, A., Fujii, T., Fujita, K., Fukushima, M., Furlich, G., Goto, T., Hanlon, W., M. Hayashi, Hayashii, Y., Hayashida, N., Hibino, K., Honda, K., Ikeda, D., Inoue, N., Ishii, T., Ishimori, R., Ito, H., Ivanov, D., Jeong, H.M., Jeong, S., Jui, C.C.H., Kadota, K., Kakimoto, F., O. Kalashev, Kasahara, K., Kawai, H., Kawakami, S., Kawana, S., Kawata, K., Kido, E., Kim, H.B., Kim, J.H., J.H. Kim, Kishigamii, S., Kitamura, S., Kitamura, Y., Kuzmin, V., Kuznetsov, M., Y.J. Kwon, Lee, K.H., Lubsandorzhiev, B., Lundquist, J.P., Machida, K., Martens, K., T. Matsuyama, Matthews, J.N., Mayta, R., Minamino, M., Mukai, K., Myers, I., Nagasawa, K., Nagataki, S., Ohnishi, M., Ohoka, H., Okuda, T., Omura, Y., Ono, M., Onogi, R., Oshima, A., Ozawa, S., Park, I.H., Piskunov, M.S., Pshirkov, M.S., Remington, J., Rodriguez, D.C., Rubtsov, G.I., Ryu, D., Sagawa, H., Sahara, R., Saito, K., Saito, Y., Sakaki, N., Sakurai, N., Scott, L.M., Seki, T., Sekino, K., Shah, P.D., Shibata, F., Shibata, T., Shimodaira, H., Shin, B.K., Shin, H.S., Smith, J.D., Sokolsky, P., Stokes, B.T., Stratton, S.R., Stroman, T.A., Suzawa, T., Takagi, Y., Takahashi, Y., Takamura, M., Takeda, M., Takeishi, R., Taketa, A., Takita, M., Tameda, Y., Tanaka, H., Tanaka, K., Tanaka, M., Thomas, S.B., Thomson, G.B., Tinyakov, P., Tkachev, I., Tokuno, H., Tomida, T., Troitsky, S., Tsunesada, Y., Tsutsumi, K., Uchihori, Y., Udo, S., Urban, F., Wong, T., Yamamoto, M., Yamane, R., Yamaoka, H., Yamazaki, K., Yang, J., Yashiro, K., Yoneda, Y., S. Yoshida, Yoshii, H., Zhezher, Y., Zundel, Z., and Uchihori, Yukio
- Abstract
We present the results of the search for ultra-high-energy photons with nine years of data from the Telescope Array surface detector. A multivariate classifier is built upon 16 reconstructed parameters of the extensive air shower. These parameters are related to the curvature and the width of the shower front, the steepness of the lateral distribution function, and the timing parameters of the waveforms sensitive to the shower muon content. A total number of two photon candidates found in the search is fully compatible with the expected background. The 95% CL limits on the diffuse flux of the photons with energies greater than 1018.0, 1018.5, 1019.0, 1019.5 and 1020.0 eV are set at the level of 0.067, 0.012, 0.0036, 0.0013, 0.0013km−2yr−1sr−1 correspondingly.
- Published
- 2019
6. Contributors
- Author
-
Acharya, Surya P., primary, Anderson, John G., additional, Ando, Masataka, additional, Atakan, Kuvvet, additional, Bevington, John, additional, Biasi, Glenn P., additional, Bilham, Roger, additional, Brune, James N., additional, Chebrov, Victor, additional, Daniell, James E., additional, Dhungel, Ranjan, additional, Dixit, Amod M., additional, Eineder, M., additional, Geiß, C., additional, Gerstenberger, Matthew C., additional, Herrmann, Marcus, additional, Hoshiba, Mitsuyuki, additional, Huyck, Charles, additional, Ishida, Mizuho, additional, G. Kossobokov, Vladimir, additional, Meghraoui, Mustapha, additional, Michel, Gero W., additional, Nekrasova, Anastasia, additional, Panza, Giuliano, additional, Parvez, Imtiyaz A., additional, Peresan, Antonella, additional, Pittore, M., additional, Rosset, Philippe, additional, Saito, K., additional, Schacher, Tom, additional, Schorlemmer, Danijel, additional, Shrestha, Surya N., additional, So, E., additional, Sobolev, Gennady, additional, Stirling, Mark W., additional, Taubenböck, H., additional, Tolis, Stavros V., additional, van Stiphout, Thomas, additional, Verrucci, Enrica, additional, Wieland, M., additional, Wiemer, Stefan, additional, Wu, Zhongliang, additional, Wyss, Max, additional, and Zechar, J. Douglas, additional
- Published
- 2014
- Full Text
- View/download PDF
7. The Capabilities of Earth Observation to Contribute along the Risk Cycle
- Author
-
Taubenböck, H., primary, Geiß, C., additional, Wieland, M., additional, Pittore, M., additional, Saito, K., additional, So, E., additional, and Eineder, M., additional
- Published
- 2014
- Full Text
- View/download PDF
8. Disorders of Taste and Smell
- Author
-
Doty, R.L., primary, Saito, K., additional, and Bromley, S.M., additional
- Published
- 2008
- Full Text
- View/download PDF
9. Lectin Repertoires in Invertebrates and Ectothermic Vertebrates: Their Roles in Embryogenesis and Innate Immunity
- Author
-
Vasta, G.R., primary, Ahmed, H., additional, Saito, K., additional, Odom, E.W., additional, and Tasumi, S., additional
- Published
- 2007
- Full Text
- View/download PDF
10. Flames
- Author
-
Saito, K., primary
- Published
- 2001
- Full Text
- View/download PDF
11. Parallel Simulation of Forest Fire Spread Due to Firebrand Transport
- Author
-
McDonough, J.M., primary, Garzon, V.E., additional, and Saito, K., additional
- Published
- 1998
- Full Text
- View/download PDF
12. NMR Imaging and Spatial Information
- Author
-
Blümich, B., primary, Blümler, P., additional, and Saito, K., additional
- Published
- 1998
- Full Text
- View/download PDF
13. Chapter D6 Radiometric age of the first occurrence of Globigerina nepenthes in the tomioka sequence, central Japan
- Author
-
Takahashi, M., primary and Saito, K., additional
- Published
- 1995
- Full Text
- View/download PDF
14. Chapter E9 A review of geological, biostratigraphical, and geochronological studies of the miura peninsula (central Japan)
- Author
-
Saito, K., primary, Inoue, C., additional, and Kanie, Y., additional
- Published
- 1995
- Full Text
- View/download PDF
15. ROBUST PARAMETER ESTIMATION PROCEDURE FOR ε-CONTAMINATED PROBABILITY DISTRIBUTION MODELS WITH UNCERTAIN GROSS-ERROR
- Author
-
Uosaki, K., primary and Saito, K., additional
- Published
- 1990
- Full Text
- View/download PDF
16. OVERVIEW OF JAPANESE PRACTICE ON INSTRUMENTATION/ AUTOMATION IN SEWAGE WORKS
- Author
-
Osato, K., primary, Okuno, N., additional, Nasuno, S., additional, and Saito, K., additional
- Published
- 1985
- Full Text
- View/download PDF
17. EQUILIBRIUM AND STABILITY OF THETA-PINCH PLASMA IN MODIFIED TOROIDAL MULTIPLE MIRROR FIELD
- Author
-
SHIINA, S., primary, SAITO, K., additional, OSANAI, Y., additional, ITAGAKI, T., additional, KARAKIZAWA, T., additional, GESSO, H., additional, TODOROKI, J., additional, KAWAKAMI, I., additional, and YOSHIMURA, H., additional
- Published
- 1976
- Full Text
- View/download PDF
18. REGIO- AND STEREOSELECTIVITY IN SUBSTITUTION AND REDOX REACTIONS OF OXO-TRANSITION METAL COMPLEXES
- Author
-
Saito, K., primary
- Published
- 1980
- Full Text
- View/download PDF
19. BLOOD-PRESSURE PALL MECHANISM OF EXOGENEOUS GABA AND GABOB
- Author
-
Ito, R., primary, Uchiyama, T., additional, Ichikawa, M., additional, Saito, K., additional, Hamatani, J., additional, and Henomatsu, H., additional
- Published
- 1978
- Full Text
- View/download PDF
20. CIRCULAR DICHROISM OF ASYMMETRICALLY DISTORTED COMPLEXES OF TRANSITION ELEMENTS
- Author
-
Saito, K., primary
- Published
- 1981
- Full Text
- View/download PDF
21. Use of Fluorescamine to Identify a Nonspecific Component of Human “Transfer Factor”
- Author
-
Gottlieb, A.A., primary, Foster, L.G., additional, Saito, K., additional, Sutcliffe, S., additional, Wrigley, P., additional, Oliver, T., additional, Cullen, M., additional, and Fairley, Gordon H., additional
- Published
- 1976
- Full Text
- View/download PDF
22. OPERATIONAL GUIDE FOR BETTER PERFORMANCE OF ANAEROBIC DIGESTION
- Author
-
Osato, K., primary, Nasuno, S., additional, Okuno, N., additional, and Saito, K., additional
- Published
- 1985
- Full Text
- View/download PDF
23. MODIFICATION OF INTRADERMAL DELAYED HYPERSENSITIVITY BY COMPONENTS OF LEUKOCYTE DIALYSATES
- Author
-
Gottlieb, A. Arthur, primary, Sutcliffe, S., additional, Saito, K., additional, Maziarz, G., additional, Tamaki, N., additional, Sakatsuji, K., additional, and Sutherland, C., additional
- Published
- 1979
- Full Text
- View/download PDF
24. Polarigraphic Observations of the Solar Corona at the Eclipse of October 12, 1958, in the South Pacific
- Author
-
SAITO, K., primary
- Published
- 1963
- Full Text
- View/download PDF
25. Prognostic Impact of Sarcopenia Assessed Using Modified Asian Working Group for Sarcopenia 2019 Criteria in Heart Failure.
- Author
-
Nakade T, Maeda D, Matsue Y, Kagiyama N, Fujimoto Y, Sunayama T, Dotare T, Jujo K, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Kasai T, Nagamatsu H, Momomura SI, and Minamino T
- Abstract
Background: Sarcopenia is a substantial therapeutic target, yet the validity of risk stratification values per the latest Asian Working Group for Sarcopenia in 2019 (AWGS 2019) remains unconfirmed in patients with heart failure. We hypothesized that using the 6-minute walk test (6MWT) to assess physical performance improves risk stratification., Methods: The study included 832 hospitalized patients with heart failure who could walk at discharge. Sarcopenia was diagnosed using both the original AWGS 2019 criteria (AWGS 2019 model) and an alternative method, in which physical performance components were replaced with the 6MWT (modified model). An <300 m 6MWT indicated low physical performance in the modified model. The primary outcome was 2-year mortality., Results: Sarcopenia and severe sarcopenia were identified in 45 and 150 patients with the AWGS 2019 model and in 75 and 108 patients with the modified model, respectively. Over the 2-year follow-up period, 145 (17.4%) deaths occurred. Adjusted Cox proportional hazard analysis showed both sarcopenia and severe sarcopenia were significantly associated with 2-year mortality in the modified model. In the AWGS 2019 model, only severe sarcopenia was significantly related to 2-year mortality. The modified model demonstrated significant net reclassification improvement (NRI) over the AWGS 2019 model (NRI, 0.396; 95% CI, 0.214-0.578; P < 0.001)., Conclusions: In patients with heart failure who were ambulatory at discharge, sarcopenia assessment with the modified AWGS 2019 model using the 6MWT as a physical performance component improved risk stratification compared with the original AWGS 2019 model. Reconsidering the current criteria to improve risk stratification is necessary to ensure timely, appropriate treatment., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
26. Human T follicular helper cells and their impact on IgE and IgG4 production across allergy, malignancy, and IgG4-related disease.
- Author
-
Akiyama M, Alshehri W, Ishigaki S, Saito K, and Kaneko Y
- Abstract
Human T follicular helper (Tfh) cells play a crucial role in orchestrating B cell differentiation, maturation, and immunoglobulin class switching. Recent studies have underscored the presence of Bcl-6 + Tfh cells not only in secondary lymphoid organs but also within tertiary lymphoid structures at inflammatory sites, emphasizing their pivotal role in disease pathogenesis. Furthermore, Tfh cells have been found to transit between lesion sites, lymph nodes, and peripheral blood, as revealed by T cell receptor repertoire analysis. Among Tfh subsets, Tfh2 cells have emerged as central orchestrators in driving the production of IgE and IgG4 from B cells. Their critical role in diseases such as allergy, malignancy, and IgG4-related disease highlights their profound impact on balancing inflammation and immune tolerance. Our current review provides the molecular characteristics of human Tfh cells, the differentiation pathways of Tfh subsets, mechanisms by which Tfh subsets induce IgE and IgG4 production, and their clinical implications in allergy, malignancy, and IgG4-related disease., Competing Interests: Conflict of interest MA has received speaking fees from AbbVie, Asahi-Kasei, Astellas, Boehringer Ingelheim, Chugai, Eisai, Eli Lilly, Janssen, Novartis, Pfizer, Taisho, UCB, Gilead Sciences. YK has received research grants from AbbVie, Eisai, Sanofi, Chugai, Mitsubishi-Tanabe, Taisho, and has received scholarship grant from Asahi-Kasei, Eisai, Boehringer Ingelheim, Taisho, and has received speaking fees from AbbVie, Asahi-Kasei, Astellas, Ayumi Pharmaceutical, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Eisai, Eli Lilly, Glaxo Smith Kline, Janssen, Novartis, Pfizer, UCB, Gilead Sciences. The rest of the authors have no conflict of interest., (Copyright © 2024 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
27. Pneumococcal vaccination, but not influenza vaccination, is negatively associated with incident dementia among Japanese older adults: The JAGES 2013-2022 prospective cohort study.
- Author
-
Iwai-Saito K, Sato K, Fujii M, and Kondo K
- Subjects
- Humans, Aged, Female, Male, Japan epidemiology, Prospective Studies, Aged, 80 and over, Incidence, Influenza, Human prevention & control, Influenza, Human epidemiology, Pneumococcal Infections prevention & control, Pneumococcal Infections epidemiology, East Asian People, Dementia epidemiology, Influenza Vaccines, Pneumococcal Vaccines administration & dosage, Vaccination
- Abstract
Background: It is unclear whether inactivated influenza vaccination (IIV) or pneumococcal vaccination are associated with the risk of dementia; however, both types of vaccination are recommended for older adults. Studies have shown that the IIV is negatively associated with incident dementia; however, the uptake of pneumococcal vaccinations has not been considered. We investigated the independent associations of IIV and 23-valent pneumococcal polysaccharide vaccine (PPSV23) with incident dementia in older adults., Methods: Health-related information on older Japanese adults was obtained through a baseline survey conducted in 2013 (baseline survey). The uptake of IIV and PPSV23 was determined in a second survey conducted in 2016 (second wave). Both surveys were conducted among independent Japanese older adults aged ≥ 65 years at the two surveys and who had not been certified as needing long-term care (LTC). In the second wave, 9,865 participants were followed up for 3.5 years (short-term follow-up), and 6,995 participants were followed up for six years and five months (long-term follow-up) until they required LTC due to dementia onset (incident dementia). A competing risk model with stabilized inverse probability weighting (SIPW) was constructed to calculate the hazard ratios (HRs) and 95 % confidence intervals (CIs) of incident dementia., Results: PPSV23 uptake was negatively associated with incident dementia among participants in both the short- and long-term follow-up periods after SIPW (short-term follow-up: HR: 0.77, 95 % CI: 0.63 - 0.95; long-term follow-up: HR: 0.83, 95 % CI: 0.70 - 0.97). Conversely, IIV uptake was not associated with incident dementia among participants in either follow-up group (short-term follow-up: HR: 0.86, 95 % CI: 0.63-1.16; long-term follow-up: HR: 0.99, 95 % CI: 0.76-1.29). The PPSV23 uptake was negatively associated with incident dementia in participants without the IIV uptake (short-term follow-up: HR: 0.44, 95 % CI: 0.24 - 0.81; long-term follow-up: HR: 0.47, 95 % CI: 0.29 - 0.76). Conversely, the IIV uptake was not associated with incident dementia regardless of the PPSV23 status (short-term follow-up: HR: 0.87, 95 % CI: 0.62 - 1.23; long-term follow-up: HR: 1.00, 95 % CI: 0.74 - 1.35)., Conclusion: Our results suggest that the PPSV23 uptake was independently associated with the incidence of dementia. However, the IIV uptake was not associated with the incidence of dementia., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. Progressive pulmonary fibrosis (PPF): Estimation of incidence and treatment rates in Japan using a claims database.
- Author
-
Kondoh Y, Ito T, Saito K, Bao H, and Sakamoto W
- Subjects
- Humans, Japan epidemiology, Aged, Male, Incidence, Female, Retrospective Studies, Middle Aged, Tacrolimus administration & dosage, Adrenal Cortex Hormones administration & dosage, Adrenal Cortex Hormones therapeutic use, Lung Diseases, Interstitial epidemiology, Lung Diseases, Interstitial therapy, Cohort Studies, Aged, 80 and over, Disease Progression, Pulmonary Fibrosis epidemiology, Pulmonary Fibrosis therapy, Databases, Factual
- Abstract
Background: Interstitial lung diseases (ILDs) are a heterogeneous group of disorders, a subset of which develop progressive pulmonary fibrosis (PPF). There is little information on the epidemiology and treatment of PPFs in Japan. This retrospective cohort study estimated the incidence probability of progression to PPFs in patients with fibrosing ILDs other than idiopathic pulmonary fibrosis in a real-world Japanese setting. Management procedures and treatment patterns were also quantified., Methods: Data were extracted from the Medical Data Vision database from 01-Jan-2012 to 28-May-2020, comprising a 6.91-year patient identification period, 1-year pre-index period, and post-index period. The primary outcome was the cumulative incidence probability of progression to PPF up to 24 months. Subgroup analyses were performed by the presence/absence of connective tissue disease-ILD and by pre-specified ILD clinical diagnosis., Results: Of the 34,960 eligible patients (mean age: 71.1 years, males: 52.5%), 14,580 (41.7%) progressed to PPF. The 24-month incidence probability of progression to PPF was 39.5%. A relatively comparable percentage of patients progressed across all ILD subtypes. Oral corticosteroids and tacrolimus were the most common therapies during the pre- and post-index periods. Treatment rates were very low in the post-index period., Conclusions: This is the first claims database study to estimate the incidence probability of progression to PPF in Japan. Progression appeared common in patients with chronic fibrosing ILDs, with comparable percentages of patients across all subtypes developing PPF at 2 years. Future studies should assess the impact of regular monitoring and early intervention on treating fibrotic ILDs and preventing progression., Competing Interests: Declaration of competing interest Yasuhiro Kondoh reports consulting fees from Boehringer Ingelheim, Chugai Pharmaceutical Co., Ltd., Healios K.K., Janssen Pharmaceutical K.K., Shionogi and Co., Ltd., and Taiho Pharmaceutical Co.; payments or honoraria from Boehringer Ingelheim, Bristol-Myers Squibb, Eisai Inc., Janssen Pharmaceutical K.K., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma, Novartis Pharma K.K., Shionogi and Co., Ltd., and Teijin Pharma. Tomohiro Ito, Kumiko Saito, Haikun Bao, and Wataru Sakamoto are employees of Boehringer Ingelheim., (Copyright © 2024 The Author. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. Evaluation of comprehensive geriatric assessment for older adults with pancreaticobiliary cancers: A retrospective observational study.
- Author
-
Suzuki Y, Saito K, Nakai Y, Oyama H, Kanai S, Noguchi K, Suzuki T, Sato T, Hakuta R, Ishigaki K, Saito T, Hamada T, Takahara N, Tateishi R, and Fujishiro M
- Abstract
Competing Interests: Declaration of Competing Interest Yousuke Nakai has received research grants by Taiho Pharmaceutical. No funding agency had input into the design and conduct of this study.
- Published
- 2024
- Full Text
- View/download PDF
30. Predictability of the neurodevelopmental assessment based on the Kyoto Scale of Psychological Development 2001 at 18-24 months of corrected age and 3 years of age in identifying cognitive impairment at 6 years of age in very preterm infants: A retrospective study at a Japanese tertiary center.
- Author
-
Haga M, Kanai M, Motojima Y, Saito K, Itoh K, Saito T, Ishiguro A, Takada E, Kunikata T, Sobajima H, Namba F, and Kabe K
- Subjects
- Humans, Male, Female, Child, Preschool, Infant, Newborn, Infant, Japan, Retrospective Studies, Infant, Extremely Premature growth & development, Developmental Disabilities diagnosis, Developmental Disabilities epidemiology, Child, Child Development, Cognitive Dysfunction diagnosis, Cognitive Dysfunction epidemiology
- Abstract
Background: It is unknown how accurately the current Japanese classification system for neurodevelopmental delay based on the assessment with the Kyoto Scale of Psychological Development (KSPD) at toddlerhood and pre-school periods predicts cognitive impairment at school age., Methods: This single-center retrospective cohort study enrolled infants born at 22-29 weeks of gestational age. At 18-24 months of corrected age and 3 years of age, the patients were categorized according to the current Japanese criteria for neurodevelopmental delay based on their overall developmental quotient calculated using the KSPD-2001. Cognitive impairment at 6 years of age was classified according to the calculated or estimated full-scale intelligence quotient. The predictability of the current Japanese classification of neurodevelopmental delay for cognitive impairment at 6 years of age was investigated., Results: Of 566 eligible patients, 364 (64 %) completed the protocol. The current classification for the neurodevelopmental delay showed significant agreement with the severity of cognitive impairment at 6 years of age. The sensitivity and specificity of the KSPD-2001-based assessment for any cognitive impairment at 6 years of age were 0.64 and 0.74 at 18-24 months of corrected age and 0.83 and 0.70 at 3 years of age. The corresponding sensitivity and specificity for moderate/severe cognitive impairment were 0.51 and 0.96 at 18-24 months of corrected age and 0.68 and 0.95 at 3 years of age., Conclusion: The KSPD-2001 is a useful tool to predict the severity of cognitive impairment at school age., Competing Interests: Declaration of competing interest The authors have no conflicts of interest to declare., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn's disease.
- Author
-
Oike T, Akizue N, Ohta Y, Koseki H, Saito M, Yokoyama Y, Imai Y, Taida T, Okimoto K, Saito K, Ogasawara S, Matsumura T, Nakagawa T, Arai M, Katsuno T, Fukuda Y, Kitsukawa Y, Kato J, and Kato N
- Abstract
Background and Study Aims: The infliximab biosimilar CT-P13 was the first biosimilar drug targeting tumor necrosis factor-α. However, its efficacy and safety in real-world clinical situations have remained insufficient. Therefore, we aimed to verify the efficacy and safety of CT-P13 in bio-naïve patients with Crohn's disease., Patients and Methods: This retrospective multicenter study compared the remission rate at week 54 between patients with Crohn's disease who were treated with originator infliximab or CT-P13. Endoscopic and laboratory findings were assessed in both groups. A total of 184 (156 originator and 28 CT-P13) patients were analyzed. Of these, 138 originator users and 19 biosimilar users completed 54-week administration., Results: The clinical remission rates in patients taking originator infliximab of CT-P13 at week 54 were 92.5 % and 100 %, respectively. The endoscopic scores of each group significantly decreased from baseline at week 54 in both groups, and the mucosal healing rate at week 54 was 53 % and 64 %, respectively. Laboratory data including C-reactive protein, serum albumin, and hemoglobin significantly improved from baseline to week 14 and 54 in both groups. Adverse events were observed more frequently in the CT-P13 group (25 % vs. 4.5 %, p = 0.0015), but severe adverse events were rare in both groups., Conclusion: The efficacy and safety of CT-P13 were comparable with those of originator infliximab in bio-naïve patients with Crohn's disease evaluated by clinical, endoscopic, and laboratory findings. This study establishes the needed groundwork for the development of a strategy for treatment with biologics in patients with Crohn's disease., Competing Interests: Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. Association and Prognostic Value of Multidomain Frailty Defined by Cumulative Deficit and Phenotype Models in Patients With Heart Failure.
- Author
-
Fujimoto Y, Matsue Y, Maeda D, Kagiyama N, Sunayama T, Dotare T, Jujo K, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Hiki M, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Wakaume K, Oka K, Momomura SI, and Minamino T
- Subjects
- Aged, 80 and over, Humans, Male, Phenotype, Prognosis, Retrospective Studies, Frailty epidemiology, Heart Failure epidemiology
- Abstract
Background: Frailty is associated with a poor prognosis in older patients with heart failure (HF). However, multidomain frailty assessment tools have not been established in patients with HF, and the association between the frailty phenotype and the deficit-accumulation frailty index in these patients is unclear. We aimed to understand this relationship and evaluate the prognostic value of the deficit-accumulation frailty index in older patients with HF., Methods: We retrospectively analyzed FRAGILE-HF cohort, which consisted of prospectively registered hospitalized patients with HF aged ≥ 65 years. The frailty index was calculated using 34 health-related items. The physical, social, and cognitive domains of frailty were evaluated using a phenotypic approach. The primary endpoint was all-cause mortality., Results: Among 1027 patients with HF (median age, 81 years; male, 58.1%; median frailty index, 0.44), a higher frailty index was associated with a higher prevalence in all domains of cognitive, physical, and social frailty defined by the phenotype model. During the 2-year follow-up period, a higher frailty index was independently associated with all-cause death even after adjustment for Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score plus log B-type natriuretic peptide (per 0.1 increase: hazard ratio, 1.21; 95% confidence interval, 1.07-1.37; P = 0.002). The addition of the frailty index to the baseline model yielded statistically significant incremental prognostic value (net reclassification improvement, 0.165; 95% confidence interval, 0.012-0.318; P = 0.034)., Conclusions: A higher frailty index was associated with a higher prevalence of all domains of frailty defined by the phenotype model and provided incremental prognostic information with pre-existing risk factors in older patients with HF., (Copyright © 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
33. Involvement of GAT2/Slc6a13 in hypotaurine uptake at fetal-facing plasma membrane of syncytiotrophoblasts at mid-to-late gestation in rats and mice.
- Author
-
Nishimura T, Araki H, Higuchi K, Noguchi S, Saito K, Hara K, Yagishita H, Akashi R, Obata S, and Tomi M
- Subjects
- Rats, Mice, Pregnancy, Female, Animals, Trophoblasts metabolism, Membrane Transport Proteins metabolism, Cell Membrane metabolism, Taurine metabolism, Taurine pharmacology, Mice, Knockout, RNA, Messenger metabolism, Placenta metabolism, Tandem Mass Spectrometry, Taurine analogs & derivatives
- Abstract
Introduction: Hypotaurine, a precursor to taurine, is known for its antioxidant properties and is prominently present in fetal plasma and the placenta. Our previous research revealed that ezrin-knockout mice experience fetal growth retardation, coinciding with reduced hypotaurine levels in fetal plasma. This study aims to elucidate the expression and role of hypotaurine transporters within the placenta., Methods: We employed quantitative RT-PCR to measure mRNA expression of GAT transporter family members in the placenta during mid-to-late gestation. LC/MS/MS was used to analyze the distribution of hypotaurine in different placental subregions. Immunohistochemistry was utilized to examine the localization of GAT2 in mice. Placental hypotaurine uptake from fetal circulation was studied via umbilical perfusion in rats., Results: Among hypotaurine transporters, GAT2 exhibited increased mRNA and protein expression in murine placenta during mid-to-late gestation. Notably, GAT2/Slc6a13 mRNA and hypotaurine were most concentrated in the labyrinth of murine placenta. In contrast, enzymes responsible for hypotaurine synthesis, such as cysteine dioxygenase, cysteine sulfinic acid decarboxylase, and 2-aminoethanethiol dioxygenase, showed minimal expression in the labyrinth. These findings suggest that GAT2 is a key determinant of hypotaurine levels in the placental labyrinth. Immunohistochemical examination unveiled that GAT2 was predominantly localized on the fetal-facing plasma membrane within syncytiotrophoblasts, which co-localized with ezrin. In rat umbilical perfusion experiments, the GAT2/3 and TauT inhibitor, SNAP-5114, significantly reduced hypotaurine extraction from fetal circulation to the placenta., Discussion: The results suggest that GAT2 plays a pivotal role in the concentrative uptake of hypotaurine from fetal plasma within syncytiotrophoblasts of the placenta., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
34. Distinct subdivisions of subcortical U-fiber regions in the gyrencephalic ferret brain.
- Author
-
Yoshino M, Shiraishi Y, Saito K, Kameya N, Hamabe-Horiike T, Shinmyo Y, Nakada M, Ozaki N, and Kawasaki H
- Subjects
- Animals, Humans, Ferrets physiology, Brain, Myelin Sheath, Axons, Cerebrum, White Matter
- Abstract
The human cerebrum contains a large amount of cortico-cortical association fibers. Among them, U-fibers are short-range association fibers located in white matter immediately deep to gray matter. Although U-fibers are thought to be crucial for higher cognitive functions, the organization within U-fiber regions are still unclear. Here we investigated the properties of U-fiber regions in the ferret cerebrum using neurochemical, neuronal tracing, immunohistochemical and electron microscopic techniques. We found that U-fiber regions can be subdivided into two regions, which we named outer and inner U-fiber regions. We further uncovered that outer U-fiber regions have smaller-diameter axons with thinner myelin compared with inner U-fiber regions. These findings may indicate functional complexity within U-fiber regions in the cerebrum., Competing Interests: Competing interests The authors declare no competing interests., (Copyright © 2023 Elsevier Ltd and Japan Neuroscience Society. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
35. Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer.
- Author
-
Kobayashi O, Taguchi A, Nakajima T, Ikeda Y, Saito K, and Kawana K
- Subjects
- Female, Humans, Human Papillomavirus Viruses, Papillomavirus E7 Proteins, Papillomaviridae, Immunotherapy, Immunity, Uterine Cervical Neoplasms, Papillomavirus Infections complications, Papillomavirus Infections therapy, Uterine Cervical Dysplasia, Oncogene Proteins, Viral
- Abstract
Cervical cancer and its precursor lesion, cervical intraepithelial neoplasia (CIN), are caused by high-risk human papillomavirus (HPV) viral infection and are highly susceptible to host immunity targeting of HPV viral proteins, which include both foreign antigens and cancer antigens expressed by tumors. Immunotherapy that induces Th1 immunoreactivity against viral proteins is expected to take advantage of this immunological regression mechanism. However, although cancer immunotherapies for cervical cancer and CIN have been developed over the past several decades, none have been commercialized. Most of these immunotherapies target the viral cancer proteins E6 and E7, which are generally the same. The reasons for the underdevelopment of HPV-targeted immunotherapy differ depending on whether the target is invasive cancer or CIN. We here summarize the developmental history of cancer immunotherapy for CIN and discuss strategies for solving the problems that led to this underdevelopment. We note that CIN is a mucosal lesion and propose that inducing mucosal immunity may be the key., Competing Interests: Declaration of competing interest GLOVACC Inc. gifted GLBL101c, IGMKK16E7, and placebo, and partially supported this clinical trial., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
36. Effect existence of aging on stutter ratio evaluated via Bayesian inference.
- Author
-
Inokuchi S, Nakanishi H, Takada A, and Saito K
- Subjects
- Humans, Infant, Newborn, Infant, Child, Preschool, Child, Adolescent, Bayes Theorem, Alleles, Aging, Microsatellite Repeats, DNA Fingerprinting
- Abstract
The stochastic behavior of the stutter ratio (SR) in capillary electrophoresis-based DNA typing is currently described and predicted using statistical models in forensic genetics. Clarifying this behavior can help obtain more objective and robust evidence to the court in terms of mixture interpretation. This study aimed to investigate the effect existence of aging on SR via a Bayesian framework. Nail scrapings and clippings were collected from 68 healthy individuals with informed consent. Samples were classified by age-class: young group (0-16 years; n = 36) and older-adult group (>61 years; n = 32). Then, they were compared in terms of their SRs for each simple repeat locus included in GlobalFiler Kit. Bayesian modeling was performed with lognormal distribution model, which implemented multiple linear regression, allele and age-class as explanatory variables. For all simple repeat loci, the median of the posterior distribution of the age-class parameter was a positive value. For CSF1PO and D7S820, the 95% credible interval of the posterior distribution did not include 0. Our data suggested that aging slightly increases the SR. These findings might help elucidate the stochastic behavior of SR., Competing Interests: Declaration of Competing Interest The authors have no conflicts of interest to declare. All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report. We certify that the submission is original work and is not under review at any other publication., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
37. "Stuffy nose" in a case of Guillain-Barré syndrome with an esophageal bezoar under enteral nutrition.
- Author
-
Mishima Y, Saito K, and Nosaka N
- Subjects
- Humans, Enteral Nutrition adverse effects, Esophagus, Guillain-Barre Syndrome diagnosis, Guillain-Barre Syndrome therapy, Bezoars, Nose Diseases
- Abstract
Competing Interests: Declaration of Competing Interest None.
- Published
- 2023
- Full Text
- View/download PDF
38. Inorganic fertilizer use and its association with rice yield gaps in sub-Saharan Africa.
- Author
-
Johnson JM, Ibrahim A, Dossou-Yovo ER, Senthilkumar K, Tsujimoto Y, Asai H, and Saito K
- Abstract
Where and which countries should receive higher priority for improving inorganic fertilizer use in rice fields in sub-Saharan Africa (SSA)? This study addressed this question by assessing the spatial variation in fertilizer use and its association with rice yield and yield gap in 24 SSA countries through a systematic literature review of peer-reviewed papers, theses, and grey literature published between 1995 and 2021. The results showed a large variation in N, P, and K fertilizer application rates and rice yield and an opportunity for narrowing the yield gap by increasing N and P rates, especially in irrigated rice systems. We identified clusters of sites/countries based on nutrient input and yield and suggested research and development strategies for improving yields and optimizing nutrient use efficiencies. Further research is essential to identify the factors causing low fertilizer use and the poor association between its use and yield in rainfed systems., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
39. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR.
- Author
-
Yuan JH, Tanaka H, Patil D, Hakimi K, Soliman S, Meagher MF, Saidian A, Walia A, Dhanji S, Liu F, Afari J, Nguyen M, Wang L, Yasuda Y, Saito K, Fujii Y, Master V, and Derweesh IH
- Subjects
- Humans, Aged, Retrospective Studies, Nephrectomy, Glomerular Filtration Rate, Carcinoma, Renal Cell pathology, Kidney Neoplasms pathology
- Abstract
Introduction: We sought to determine whether loss of renal function increases risk of recurrence and metastases in renal cell carcinoma (RCC), and whether this impact was age-related., Materials and Methods: We performed a retrospective analysis of the International Marker Consortium for Renal Cancer (INMARC) registry. Patients were separated into younger (<65 years old) and elder (≥65 years old) age groups, and rates of de novo estimated glomerular filtration rate (eGFR<45 mL/min/1.73m2 [eGFR<45]) were calculated. Multivariable analysis (MVA) was conducted for predictors of progression-free survival (PFS) and all-cause mortality (ACM). Kaplan-Meier Analysis (KMA) was conducted for PFS and overall survival (OS) in younger and elder age groups stratified by functional status., Results: We analyzed 1805 patients (1113 age<65, 692 age≥65). On MVA in patients <65, de novo eGFR<45 was independently associated with greater risk for worsened progression (HR=1.61, P=.038) and ACM (HR=1.82, P=.018). For patients ≥65, de novo eGFR<45 was not independently associated with progression (P=.736), or ACM (P=.286). Comparing patients with de novo eGFR<45 vs. eGFR ≥45, KMA demonstrated worsened 5-year PFS and OS in patients <65 (PFS: 68% vs. 86%, P<.001; OS: 73% vs. 90%, P<.001), while in patients ≥65, only 5-year OS was worsened (77% vs. 81%, P<.021)., Conclusion: Development of de novo eGFR<45 was associated with more profound impact on patients <65 compared to patients ≥65, being an independent risk factor for PFS and ACM. The mechanisms of this phenomenon are unclear but underscore desirability for nephron preservation when safe and feasible in younger patients., (Copyright © 2022. Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
40. Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure.
- Author
-
Fujimoto Y, Maeda D, Kagiyama N, Sunayama T, Dotare T, Jujo K, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Hiki M, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Wakaume K, Oka K, Momomura SI, and Matsue Y
- Subjects
- Humans, Aged, Prognosis, Prospective Studies, Prevalence, Cachexia diagnosis, Cachexia epidemiology, Cachexia etiology, Sarcopenia diagnosis, Sarcopenia epidemiology, Sarcopenia etiology, Heart Failure complications, Heart Failure diagnosis, Heart Failure epidemiology
- Abstract
Background: No study with an adequate patients' number has examined the relationship/overlap between sarcopenia and cachexia. We examined the prevalence of the overlap and prognostic implications of sarcopenia and cachexia in older patients with heart failure using well-accepted definitions., Methods: This was a post-hoc sub-analysis of the FRAGILE-HF study, a prospective, multicenter, observational study conducted at 15 hospitals in Japan. In total, 905 hospitalized older patients were classified into four groups based on the presence or absence of cachexia and/or sarcopenia, which were defined according to the Evans and Asian Working Group for Sarcopenia criteria revised in 2019, respectively. The primary endpoint was 2-year all-cause mortality., Results: Cachexia and sarcopenia prevalence rates were 32.7% and 22.7%, respectively. Patients were classified into the non-cachexia/non-sarcopenia (55.7%), cachexia/non-sarcopenia (21.7%), non-cachexia/sarcopenia (11.6%), and cachexia/sarcopenia (11.0%) groups. During the 2-year follow-up period after discharge, 158 (17.5%) all-cause deaths (124 cardiovascular deaths [CVD] and 34 non-CVD) were observed. The cachexia/sarcopenia group had the lowest body fat mass and exhibited significantly higher mortality rates (log-rank P < 0.001). Cox proportional hazard analysis revealed that cachexia/sarcopenia was an independent prognostic factor after adjusting for known prognostic factors (versus non-cachexia/non-sarcopenia: hazard ratio, 2.78; 95% confidence interval, 1.80-4.29; P < 0.001). Neither cachexia/non-sarcopenia nor non-cachexia/sarcopenia were significantly associated with all-cause mortality compared with non-cachexia/non-sarcopenia., Conclusions: Cachexia and sarcopenia are prevalent among older hospitalized patients with heart failure; nonetheless, the overlap is not as prominent as previously expected. The presence of cachexia and sarcopenia is a risk factor for all-cause mortality., Competing Interests: Declaration of Competing Interest Yuya Matsue and Takatoshi Kasai are affiliated with a department-sponsored by Philips Respironics, ResMed, Teijin Home Healthcare, and Fukuda Denshi. Yuya Matsue received an honorarium from Otsuka Pharmaceutical Co. and Novartis Japan. Nobuyuki Kagiyama received grants from Philips, Asahi KASEI Corporation, Toho Holdings Co. Ltd., Inter Reha Co. Ltd., and EchoNous. Inc., as well as research grants from AMI Inc. outside of the submitted work. Kentaro Kamiya received research funding from Eiken Chemical Co. Ltd. The other authors declare no conflicts of interest., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
41. Prevalence of human T-lymphotropic virus type I in patients with psoriasis and its effect on treatment choice: A multicenter observational study.
- Author
-
Yonekura K, Tsuruta N, Miyagi T, Koike Y, Higashi Y, Nakahara T, Ohata C, Kaneko S, Yamaguchi M, Saito K, Yanase T, and Imafuku S
- Subjects
- Humans, Prevalence, Human T-lymphotropic virus 1, Psoriasis drug therapy, Psoriasis epidemiology, HTLV-I Infections complications, HTLV-I Infections epidemiology
- Abstract
Competing Interests: Conflict of interest Sakae Kaneko received honoraria from Eli Lilly Japan. Other authors have no conflict of interest to declare.
- Published
- 2023
- Full Text
- View/download PDF
42. Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
- Author
-
Fujimoto Y, Maeda D, Kagiyama N, Sunayama T, Dotare T, Jujo K, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Hiki M, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Wakaume K, Oka K, Momomura SI, and Matsue Y
- Subjects
- Humans, Prognosis, Stroke Volume, Risk Factors, Ventricular Function, Left, Heart Failure diagnosis
- Abstract
Background: The incremental prognostic value of the six-minute walking test over conventional risk factors has not been evaluated in an adequate number of patients with heart failure with preserved ejection fraction (HFpEF). Therefore, we aimed to examine its prognostic significance using data from the FRAGILE-HF study., Methods and Results: A total of 513 older patients who were hospitalized for worsening heart failure were examined. Patients were classified according to the tertiles of six-minute walking distance (6MWD): T1 (<166 m), T2 (166-285 m), and T3 (≥285 m). During the 2-year follow-up period after discharge, 90 all-cause deaths occurred. Kaplan-Meier curves showed that the T1 group had significantly higher event rates than the other groups (log-rank p = 0.007). Cox proportional hazard analysis revealed that the T1 group was independently associated with lower survival, even after adjusting for conventional risk factors (T3: hazard ratio 1.79, 95% confidence interval 1.02-3.14, p = 0.042). The addition of the 6MWD to the conventional prognostic model showed a statistically significant incremental prognostic value (net reclassification improvement 0.27, 95% confidence interval 0.04-0.49; p = 0.019)., Conclusions: The 6MWD is associated with survival in patients with HFpEF and has an incremental prognostic value over conventional well-validated risk factors., Competing Interests: Declaration of Competing Interest Y. M. and T. K. are affiliated with a department sponsored by Philips Respironics, ResMed, Teijin Home Healthcare, and Fukuda Denshi. Y. M. received an honorarium from Otsuka Pharmaceutical Co. and Novartis Japan. N. K. was affiliated with a department endowed by grants from Philips, Asahi KASEI Corporation, Toho Holdings Co., Ltd., and Inter Reha Co., Ltd., received research grants from EchoNous. Inc. and AMI Inc., and received an honorarium from Novartis Japan outside the submitted work. K. K. received funding outside the submitted work from Eiken Chemical Co., Ltd. and SoftBank Cor. Ltd. The other authors have no conflicts of interest to declare. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
43. Roles of TRPM4 in immune responses in keratinocytes and identification of a novel TRPM4-activating agent.
- Author
-
Otsuka Saito K, Fujita F, Toriyama M, Utami RA, Guo Z, Murakami M, Kato H, Suzuki Y, Okada F, Tominaga M, and Ishii KJ
- Subjects
- Humans, HEK293 Cells, Keratinocytes metabolism, Cytokines metabolism, Tumor Necrosis Factor-alpha metabolism, Immunity, Dermatitis, TRPM Cation Channels metabolism
- Abstract
The skin is a protective interface between the internal organs and environment and functions not only as a physical barrier but also as an immune organ. However, the immune system in the skin is not fully understood. A member of the thermo-sensitive transient receptor potential (TRP) channel family, TRPM4, which acts as a regulatory receptor in immune cells, was recently reported to be expressed in human skin and keratinocytes. However, the function of TRPM4 in immune responses in keratinocytes has not been investigated. In this study, we found that treatment with BTP2, a known TRPM4 agonist, reduced cytokine production induced by tumor necrosis factor (TNF) α in normal human epidermal keratinocytes and in immortalized human epidermal keratinocytes (HaCaT cells). This cytokine-reducing effect was not observed in TRPM4-deficient HaCaT cells, indicating that TRPM4 contributed to the control of cytokine production in keratinocytes. Furthermore, we identified aluminum potassium sulfate, as a new TRPM4 activating agent. Aluminum potassium sulfate reduced Ca
2+ influx by store-operated Ca2+ entry in human TRPM4-expressing HEK293T cells. We further confirmed that aluminum potassium sulfate evoked TRPM4-mediated currents, showing direct evidence for TRPM4 activation. Moreover, treatment with aluminum potassium sulfate reduced cytokine expression induced by TNFα in HaCaT cells. Taken together, our data suggested that TRPM4 may serve as a new target for the treatment of skin inflammatory reactions by suppressing the cytokine production in keratinocytes, and aluminum potassium sulfate is a useful ingredient to prevent undesirable skin inflammation through TRPM4 activation., Competing Interests: Declaration of competing interest The authors have no conflicts of interest to declare., (Copyright © 2023 Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
44. Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertension.
- Author
-
Misaki Y, Minakata D, Ibe T, Gomyo A, Yoshimura K, Kimura SI, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Matsumi S, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Hatano K, Nakasone H, Imadome KI, Wada H, Kako S, Oshiro H, Tanaka A, and Kanda Y
- Subjects
- Adult, Humans, Pulmonary Artery, Chronic Disease, Epstein-Barr Virus Infections diagnosis, Hematopoietic Stem Cell Transplantation, Virus Diseases, Hypertension complications
- Abstract
Chronic active Epstein-Bar virus infection (CAEBV) is known to cause various symptoms. Although pulmonary artery hypertension (PAH) has been reported as a cardiovascular complication of CAEBV, the mechanisms of PAH and the effects of treatment have not been fully elucidated. We experienced 4 adult patients with CAEBV complicated by PAH. All of them received treatment for PAH with a vasodilator followed by chemotherapy with or without allogeneic hematopoietic cell transplantation for CAEBV. In all of these patients, the transtricuspid pressure gradient improved under treatment with vasodilator, and further improvement was observed under treatment for CAEBV in 3 patients. Autopsy was performed in 2 patients, which revealed EBER-positive cells and a change in the pulmonary artery at each stage in the pathology. In conclusion, EBV-infected cells can cause vasculitis and finally PAH. However, PAH complicated with CAEBV can be improved by PAH medication and treatment of CAEBV., Competing Interests: Declaration of competing interest The authors have no conflict of interest directly relevant to the content of this article., (Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
45. Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
- Author
-
Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Cheng AL, Vogel A, Tovoli F, Ueshima K, Aikata H, López CL, Pracht M, Meng Z, Daniele B, Park JW, Palmer D, Tamai T, Saito K, Dutcus CE, and Lencioni R
- Subjects
- Humans, Retrospective Studies, Sorafenib therapeutic use, Antineoplastic Agents therapeutic use, Carcinoma, Hepatocellular pathology, Liver Neoplasms pathology
- Abstract
Background & Aims: Validated surrogate endpoints for overall survival (OS) are important for expediting the clinical study and drug-development processes. Herein, we aimed to validate objective response as an independent predictor of OS in individuals with unresectable hepatocellular carcinoma (HCC) receiving systemic anti-angiogenic therapy., Methods: We investigated the association between objective response (investigator-assessed mRECIST, independent radiologic review [IRR] mRECIST and RECIST v1.1) and OS in REFLECT, a phase III study of lenvatinib vs. sorafenib. We conducted landmark analyses (Simon-Makuch) of OS by objective response at 2, 4, and 6 months after randomization., Results: Median OS was 21.6 months (95% CI 18.6-24.5) for responders (investigator-assessed mRECIST) vs. 11.9 months (95% CI 10.7-12.8) for non-responders (hazard ratio [HR] 0.61; 95% CI 0.49-0.76; p <0.001). Objective response by IRR per mRECIST and RECIST v1.1 supported the association with OS (HR 0.61; 95% CI 0.51-0.72; p <0.001 and HR 0.50; 95% CI 0.39-0.65; p <0.001, respectively). OS was significantly prolonged for responders vs. non-responders (investigator-assessed mRECIST) at the 2-month (HR 0.61; 95% CI 0.49-0.76; p <0.001), 4-month (HR 0.63; 95% CI 0.51-0.80; p <0.001), and 6-month (HR 0.68; 95% CI 0.54-0.86; p <0.001) landmarks. Results were similar when assessed by IRR, with both mRECIST and RECIST v1.1. An exploratory multivariate Cox regression analysis identified objective response by investigator-assessed mRECIST (HR 0.55; 95% CI 0.44-0.68; p <0.0001) and IRR-assessed RECIST v1.1 (HR 0.49; 95% CI, 0.38-0.64; p <0.0001) as independent predictors of OS in individuals with unresectable HCC., Conclusions: Objective response was an independent predictor of OS in individuals with unresectable HCC in REFLECT; additional studies are needed to confirm surrogacy. Participants achieving a complete or partial response by mRECIST or RECIST v1.1 had significantly longer survival vs. those with stable/progressive/non-evaluable disease., Gov Number: NCT01761266., Impact and Implications: This analysis of data taken from a completed clinical trial (REFLECT) looked for any link between objective response and overall survival time in individuals with unresectable HCC receiving anti-angiogenic treatments. Significantly longer median overall survival was found for responders (21.6 months) vs. non-responders (11.9 months). Overall survival was also significantly longer for responders vs. non-responders (based on objective response status at 2, 4, and 6 months) in the landmark analysis. Our results indicate that objective response is an independent predictor of overall survival in this setting, confirming its validity as a rapid marker of efficacy that can be applied in phase II trials; however, further validation is required to determine is validity for other systemic treatments (e.g. immunotherapies), or as a surrogate of overall survival., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
46. A targeted literature review of the burden of illness for spine-related neuropathic pain in Japan.
- Author
-
Kaito T, Crawford B, Takada S, Yokoyama M, Saito K, Usuba K, and Okuizumi K
- Subjects
- Humans, Quality of Life, Japan epidemiology, Cost of Illness, Spine, Spinal Diseases complications, Neuralgia etiology
- Abstract
Background: Neuropathic pain (NeP) is pain provoked by damage or disease in the nervous system and about one in three Japanese patients with spinal disorders are highly likely to have NeP. The humanistic and economic burden of illness (BOI) of spine-related NeP represents unmet medical needs that should be addressed. The purpose of this targeted literature review was to synthesize the available evidence on the BOI of spine-related NeP in Japanese patients., Methods: PubMed and ICHUSHI were searched for relevant studies published between January 2010 and December 2020, in English or Japanese. The population included patients with one or more of prespecified spinal disorders and NeP, and outcomes of interest were data related to humanistic or economic burden., Results: Out of 32 studies that assessed the BOI of spine-related disorders in Japan, only six specifically assessed spine-related NeP. Among these studies, five different validated questionnaires were used to measure humanistic burden. Spine-related NeP was consistently shown to be related with a poorer health-related quality of life and higher levels of anxiety and depression compared to the general population as well as patients with nociceptive pain. No articles directly evaluating economic burden were identified in this search, so an exploratory analysis was conducted. Reduction in work productivity by people experiencing spine-related NeP in the whole of Japan were estimated to total JPY 172,266,780,480 per year., Conclusions: The humanistic burden of spine-related NeP on Japanese patients is considerable, not only physically but also mentally. Exploratory analysis of the economic burden illustrates the possibility of substantial societal costs associated with NeP. In order to better understand the depth of BOI and the unmet medical need caused by spine-related NeP, further studies on real-world outcomes are recommended., Competing Interests: Declaration of competing interest T Kaito has received consulting fees from Daiichi Sankyo Co., Ltd. K Okuizumi, S Takada, M Yokoyama and K Saito are full-time employees of Daiichi Sankyo Co., Ltd. B Crawford and K Usuba are full-time employees of Syneos Health. Syneos Health received funding from Daiichi Sankyo Co., Ltd. to conduct the data collection, data analysis and manuscript development., (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
47. MTR4 adaptor PICT1 functions in two distinct steps during pre-rRNA processing.
- Author
-
Miyao S, Saito K, Oshima R, Kawahara K, and Nagahama M
- Subjects
- Humans, Exosome Multienzyme Ribonuclease Complex genetics, Nuclear Proteins, Oligonucleotides, RNA Processing, Post-Transcriptional, RNA, Ribosomal, 5.8S, RNA, Small Interfering, Saccharomyces cerevisiae genetics, Saccharomyces cerevisiae Proteins genetics, RNA Precursors genetics, RNA Helicases genetics, Tumor Suppressor Proteins genetics
- Abstract
Ribosome biogenesis proceeds with the successive cleavage and trimming of the large 47S rRNA precursor, where the RNA exosome plays major roles in concert with the Ski2-like RNA helicase, MTR4. The recent finding of a consensus amino acid sequence, the arch-interacting motif (AIM), for binding to the arch domain in MTR4 suggests that recruitment of the RNA processing machinery to the maturing pre-rRNA at appropriate places and timings is mediated by several adaptor proteins possessing the AIM sequence. In yeast Saccharomyces cerevisiae, Nop53 plays such a role in the maturation of the 3'-end of 5.8S rRNA. Here, we investigated the functions of PICT1 (also known as GLTSCR2 or NOP53), a mammalian ortholog of Nop53, during ribosome biogenesis in human cells. PICT1 interacted with MTR4 and exosome in an AIM-dependent manner. Overexpression of PICT1 mutants defecting AIM sequence and siRNA-mediated depletion of PICT1 showed that PICT1 is involved in two distinct pre-rRNA processing steps during the generation of 60S ribosomes; first step is the early cleavage of 32S intermediate RNA, while the second step is the late maturation of 12S precursor into 5.8S rRNA. The recruitment of MTR4 and RNA exosome via the AIM sequence was required only during the late processing step. Although, the depletion of MTR4 and PICT1 induced stabilization of the tumor suppressor p53 protein in cancer cell lines, the depletion of the exosome catalytic subunits, RRP6 and DIS3, did not exert such an effect. These results suggest that recruitment of the RNA processing machinery to the 3'-end of pre-5.8S rRNA may be involved in the induction of the nucleolar stress response, but the pre-rRNA processing capabilities themselves were not involved in this process., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Masami Nagahama reports financial support was provided by Japan Society for the Promotion of Science., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
48. Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
- Author
-
Sugino Y, Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, and Inoue T
- Subjects
- Male, Humans, Prostate surgery, Prostate pathology, Prostate-Specific Antigen, Cohort Studies, Japan, Prostatectomy, Risk Factors, Retrospective Studies, Robotics, Prostatic Neoplasms pathology
- Abstract
Introduction: We aimed to examine the relationship between D'Amico intermediate-risk and pathological grade group 1 (pGG1) after robot-assisted radical prostatectomy (RARP)., Patients and Methods: In this retrospective multicenter cohort study, D'Amico intermediate-risk prostate cancer patients who did not receive neoadjuvant therapy, and underwent RARP at 10 institutions in Japan were examined for preoperative factors associated with pGG1., Results: In total, we enrolled 1161 D'Amico intermediate-risk prostate cancer patients. The pGG1 and pGG ≥2 groups comprised 73 (6.3%), and 1088 (93.7%) cases, respectively. Biochemical recurrence-free survival (BCRFS) of the pGG1 group was equivalent to that of the D'Amico low-risk patients. Among the 3 D'Amico intermediate-risk factors (IRF), the pGG1-rate was 24% with prostate-specific antigen (PSA) of 10 to 20 ng/mL alone, and 30% with cT2b alone. Both groups had significantly higher pGG1-rates than other groups. Down-grading from biopsy GG ≥2 to pGG1 was relatively rare (3.9%). Patients with pGG1 were further stratified by prostate volume (PV) (cutoff, 40 cc) among patients with one IRF and PSA of 10 to 20 ng/mL. Patients with one IRF, PSA of 10 to 20 ng/mL, and PV >40 cc had a relatively good BCRFS similar to that of the D'Amico low-risk group., Conclusion: Among intermediate-risk prostate cancer patients, those with pGG1 have a good prognosis. Downgrading from biopsy GG ≥2 is rare, and definitive treatment may be recommended for patients with biopsy GG ≥2. Patients with one IRF, PSA of 10 to 20 ng/mL, and PV >40 cc who are eligible for RARP may be candidates for active surveillance., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
49. Auditory precision hypothesis-L2: Dimension-specific relationships between auditory processing and second language segmental learning.
- Author
-
Saito K, Kachlicka M, Suzukida Y, Petrova K, Lee BJ, and Tierney A
- Subjects
- Auditory Perception, Humans, Language, Phonetics, Multilingualism, Speech Perception
- Abstract
Growing evidence suggests a broad relationship between individual differences in auditory processing ability and the rate and ultimate attainment of language acquisition throughout the lifespan, including post-pubertal second language (L2) speech learning. However, little is known about how the precision of processing of specific auditory dimensions relates to the acquisition of specific L2 segmental contrasts. In the context of 100 late Japanese-English bilinguals with diverse profiles of classroom and immersion experience, the current study set out to investigate the link between the perception of several auditory dimensions (F3 frequency, F2 frequency, and duration) in non-verbal sounds and English [r]-[l] perception and production proficiency. Whereas participants' biographical factors (the presence/absence of immersion) accounted for a large amount of variance in the success of learning this contrast, the outcomes were also tied to their acuity to the most reliable, new auditory cues (F3 variation) and the less reliable but already-familiar cues (F2 variation). This finding suggests that individuals can vary in terms of how they perceive, utilize, and make the most of information conveyed by specific acoustic dimensions. When perceiving more naturalistic spoken input, where speech contrasts can be distinguished via a combination of numerous cues, some can attain a high-level of L2 speech proficiency by using nativelike and/or non-nativelike strategies in a complementary fashion., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
50. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
- Author
-
Kubota H, Kunisawa K, Niijima M, Hirakawa M, Mori Y, Hasegawa M, Fujigaki S, Fujigaki H, Yamamoto Y, Saito K, Nabeshima T, and Mouri A
- Subjects
- Animals, Kynurenic Acid metabolism, Mice, Mice, Inbred C57BL, Phencyclidine, Prepulse Inhibition, Quinolinic Acid metabolism, RNA, Messenger, Kynurenine metabolism, Kynurenine 3-Monooxygenase genetics, Kynurenine 3-Monooxygenase metabolism
- Abstract
Phencyclidine (PCP) causes mental symptoms that closely resemble schizophrenia through the inhibition of the glutamatergic system. The kynurenine (KYN) pathway (KP) generates metabolites that modulate glutamatergic systems such as kynurenic acid (KA), quinolinic acid (QA), and xanthurenic acid (XA). Kynurenine 3-monooxygenase (KMO) metabolizes KYN to 3-hydroxykynurenine (3-HK), an upstream metabolite of QA and XA. Clinical studies have reported lower KMO mRNA and higher KA levels in the postmortem brains of patients with schizophrenia and exacerbation of symptoms in schizophrenia by PCP. However, the association between KMO deficiency and PCP remains elusive. Here, we demonstrated that a non-effective dose of PCP induced impairment of prepulse inhibition (PPI) in KMO KO mice. KA levels were increased in the prefrontal cortex (PFC) and hippocampus (HIP) of KMO KO mice, but 3-HK levels were decreased. In wild-type C57BL/6 N mice, the PPI impairment induced by PCP is exacerbated by KA, while attenuated by 3-HK, QA and XA. Taken together, KMO KO mice were vulnerable to the PPI impairment induced by PCP through an increase in KA and a decrease in 3-HK, suggesting that an increase in the ratio of KA to 3-HK (QA and XA) may play an important role in the pathophysiology of schizophrenia., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.